High prevalence of erythromycin resistance of streptococcus pyogenes in Greek children

Pediatric Infectious Disease Journal

Volumn 20, Issue 9, 2001, Pages 863-868

  Syrogiannopoulos, George A ^a   Grivea, Ioanna N ^a   Fitoussi, Frederic ^b   Doit, Catherine ^b   Katopodis, George D ^a   Bingen, Edouard ^b   Beratis, Nicholas G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Erythromycin resistance; Greece; Streptococcus pyogenes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFPROZIL; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CHILD; GREECE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ADOLESCENT; AGE DISTRIBUTION; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; GREECE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PHARYNGITIS; PREVALENCE; PROBABILITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 0034827938     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200109000-00008     Document Type: Article

References (38)

1. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: Characterization of South African isolates
2. Macrolide resistance in Streptococcus pyogenes in Europe
3. A community outbreak of invasive and non-invasive group A beta-haemolytic streptococcal disease in a town in South Wales
4. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada
5. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995
6. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy
7. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: An epidemiological and molecular study
8. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy
9. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain
10. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain
11. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain
12. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains
13. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: Influence of macrolide resistance on clinical and microbiological outcomes
14. Streptococcus pyogenes erythromycin resistance in Italy
15. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
16. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptibe (M phenotype) Streptococcus pyogenes: Results of a Spanish multicentre study in 1998
17. Susceptibility of 2039 consecutive isolates of Streptococcus pyogenes from pharyngeal exudate samples: Results of a Spanish multicenter surveillance study over a 1-year period (1998-1999)
18. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
19. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: A common resistance pattern mediated by an efflux system
20. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes
21. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants
22. Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece
23. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland
24. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: Examination of 301 strains isolated in the United States between 1994 and 1997
25. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S9
26. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients
27. Streptococcus pyogenes isolated in Portugal: Macrolide resistance phenotypes and correation with T types
28. Mechanisms of macrolide resistance in Streptococcus pneumoniae and S. pyogenes from Central and Eastern European countries
29. In-vitro susceptibility of group A beta-haemolytic streptococci (GABHS) to penicillin, erythromycin, clarithromycin and azithromycin in Styria, Austria
30. Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin
31. Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae
32. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
33. Erythromycin resistance genes in group A streptococci in Finland
34. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
35. Prevalence and genotypes of macrolide resistant Streptococcus pneumoniae and betahemolytic streptococci in the Netherlands, Denmark and Luxemburg
36. Different erythromycin resistance mechanisms in group C and group G streptococci
37. Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece
38. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life